AI assistant
Sending…
ACADIA PHARMACEUTICALS INC — Director's Dealing 2017
Mar 10, 2017
31237_dirs_2017-03-10_9e57599a-02c2-4113-8401-4a9ebdc15fde.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2017-03-08
Reporting Person: Baity Glenn (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-03-08 | Stock Option (right to buy) | $36.54 | A | 46875 | Acquired | 2027-03-07 | Common Stock (46875) | Direct |
Footnotes
F1: 25% of the shares subject to the Stock Option vest and become exercisable on March 8, 2018. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.
More from ACADIA PHARMACEUTICALS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Regulatory Filings
2026
May 6
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20